Total Funding
84
49
Total FundingVenture - Series Unknown raised
Growth Score
-4 pts
Heat Score
-9 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
18836
Interius BioTherapeutics is a biotechnology company that delivers genetic medicines for patients.
Acquired by 
Kite Pharma
Saar Gill: Founder
Philip R. Johnson: Chief Executive Officer
About the Company
Interius BioTherapeutics is a company that engineers genetic medicine therapeutics. It develops proprietary vectors for the precision delivery of genetic medicines to patients. The company's pipeline includes treatments for challenging diseases in oncology and autoimmunity.
